Ziopharm Oncology reported $9.08M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Amgen AMGN:US $ 3.74B 804M
AstraZeneca AZN:LN 10.51B 1.79B
Baxter International BAX:US $ 3544M 376M
Biogen BIIB:US $ 1921.1M 225.6M
Bioline Rx BLRX:US 6.08M 519K
Bristol Myers Squibb BMY:US $ 9.1B 247M
Corcept Therapeutics CORT:US $ 66.92M 4.76M
Curis CRIS:US $ 17.19M 1.49M
Eleven Biotherapeutics EBIO:US 835K 10.21M
Gilead Sciences GILD:US $ 6393M 89M
GlaxoSmithKline GSK:LN 6.98B 1.65B
Immunogen IMGN:US $ 60.93M 1.62M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
Intrexon XON:US $ 49.92M 5.21M
Johnson & Johnson JNJ:US $ 17.56B 2.4B
Karyopharm Therapeutics KPTI:US $ 82.26M 2.95M
Merk MRK:US $ 10332M 386M
Novartis NOVN:VX 9.96B 998M
Pfizer PFE:US $ 15788M 3271M
Ptc Therapeutics PTCT:US $ 235.26M 14.7M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Tg Therapeutics TGTX:US $ 68.89M 26.38M
Verastem VSTM:US $ 19.58M 2.52M
YTE INCY:US $ 616.69M 135.42M
Ziopharm Oncology ZIOP:US $ 9.08M 1.97M